on INNATE PHARMA (EPA:IPH)
Innate Pharma Announces Upcoming Conference Call and Webcast
Innate Pharma SA, listed on Euronext Paris and Nasdaq, will hold a conference call on August 14, 2026. The event will feature talks by key executives such as CEO Jonathan Dickinson and CFO Frédéric Lombard. The webcast is accessible online, and replays will be available on the company's website.
Based in Marseille, Innate Pharma specializes in immunotherapies for cancer, focusing on antibody-drug conjugates like IPH4502. The company collaborates with biopharmaceutical leaders like AstraZeneca to advance its clinical-stage assets, including monalizumab for lung cancer.
Further information about the event and the company is accessible through their official website and relevant financial authorities' portals.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news